US Stock MarketDetailed Quotes
EW Edwards Lifesciences
- 70.480
- +0.100+0.14%
Close Nov 22 16:00 ET
- 70.480
- 0.0000.00%
Post 20:01 ET
41.57BMarket Cap10.21P/E (TTM)
71.000High69.960Low2.71MVolume70.310Open70.380Pre Close191.00MTurnover0.47%Turnover Ratio30.64P/E (Static)589.80MShares96.12052wk High4.35P/B41.14BFloat Cap58.93052wk Low--Dividend TTM583.75MShs Float131.730Historical High--Div YieldTTM1.48%Amplitude1.000Historical Low70.435Avg Price1Lot Size
About Edwards Lifesciences Company
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.
Company Profile
SymbolEW
Company NameEdwards Lifesciences
Listing DateMar 27, 2000
Founded1958
CEOMr. Bernard J. Zovighian
MarketNYSE
Employees19800
Fiscal Year Ends12-31
Address1 Edwards Way
CityIrvine
ProvinceCalifornia
CountryUnited States of America
Zip Code92614
Phone1-949-250-2500
Websitehttp://www.edwards.com
Company Executives
- Name
- Position
- Salary
- Bernard J. Zovighian
- Director and Chief Executive Officer
- 12.87M
- Scott B. Ullem
- Corporate Vice President and Chief Financial Officer
- 5.95M
- Wayne Markowitz
- General Manager and Senior Vice President, Surgical Structural Heart
- --
- Andrew M. Dahl
- Principal Accounting Officer, Senior Vice President and Corporate Controller
- --
- Catherine M. Szyman
- Corporate Vice President, Critical Care
- 4.34M
- Daveen Chopra
- Corporate Vice President, Transcatheter Mitral and Tricuspid Therapies
- --
- Jean-Luc M. Lemercier
- Corporate Vice President, Europe, Middle East, Africa, Canada and Latin America
- --
- Donald E. Bobo,Jr
- Corporate Vice President
- 4.29M
- Larry L. Wood
- Corporate Vice President and Group President, Transcatheter Aortic Valve Replacement and Surgical Structural Heart
- 5.40M
- Daniel J. Lippis
- Corporate Vice President, JAPAC
- --
- Nicholas J. Valeriani
- Chairman of the Board
- 347.97K
- Dr. David T. Feinberg, M.D.,PhD
- Director
- --
- Leslie Stone Heisz
- Independent Director
- 356.42K
- Paul A. Laviolette
- Independent Director
- 329.97K
- Kieran T. Gallahue
- Independent Director
- 335.06K
- Leslie C. Davis
- Independent Director
- --
- Ramona Sequeira
- Independent Director
- 334.97K
- Steven R. Loranger
- Independent Director
- 335.06K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data